Articles published in Journal of Vaccines & Vaccination have been cited by esteemed scholars and scientists all around the world. Journal of Vaccines & Vaccination has got h-index 24, which means every article in Journal of Vaccines & Vaccination has got 24 average citations.
Following are the list of articles that have cited the articles published in Journal of Vaccines & Vaccination.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
67 | 60 | 59 | 65 | 71 | 11 | 19 | 26 | 45 | 44 | 52 | 59 | 54 | 13 | 14 |
Research, Review articles and Editorials |
14 | 14 | 19 | 41 | 29 | 11 | 15 | 16 | 17 | 34 | 40 | 42 | 38 | 10 | 10 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
38 | 46 | 40 | 30 | 42 | 0 | 4 | 10 | 28 | 10 | 12 | 17 | 21 | 3 | 4 |
Conference proceedings |
18 | 8 | 32 | 23 | 0 | 0 | 112 | 104 | 154 | 315 | 180 | 116 | 110 | 122 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
121 | 206 | 193 | 258 | 232 | 212 | 200 | 205 | 224 | 245 | 110 | 61 | 22 | 20 | 0 |
Journal total citations count | 2341 |
Journal impact factor | 2.87 |
Journal 5 years impact factor | 3.73 |
Journal cite score | 4.69 |
Journal h-index | 24 |
PREVALENCE OF HEPATITIS B VIRUS INFECTION IN HEALTH CARE WORKERS OF A TERTIARY CARE HOSPITAL
Novel Aspects and Strategies in Vaccination
Hexavalent vaccines: What can we learn from head-to-head studies?
Immunogenicity and safety of a fully liquid DTaP-IPV-HB-PRP?T hexavalent vaccine compared with the standard of care in infants in the Republic of Korea.
DTaP-IPV-HepB-Hib Vaccine (Hexyon®): An Updated Review of its Use in Primary and Booster Vaccination.
DTaP-IPV-Hep B-Hib vaccine (Hexyon ® /Hexacima ® ): a guide to its use in the primary and booster vaccination of infants and toddlers in Europe
Combined immunogenicity data for a new DTaP-IPV-Hep B-PRP-T vaccine (Hexaxim) following primary series administration at 2, 4, 6 months of age in Latin America.
Hexavalent vaccines in infants: a systematic literature review and meta-analysis of the solicited local and systemic adverse reactions of two hexavalent vaccines.
Persistence of hepatitis B immune memory until 9-10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP?T vaccination at 2, 4 and 6 months.
Hexavalent vaccines for immunization in paediatric age
Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants.
New perspectives for hexavalent vaccines.
Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration.
DTaP-IPV-Hep B-Hib vaccine (Hexaxim®) : a review of its use in primary and booster vaccination.
Novel Aspects and Strategies in Vaccination
Development of Prophylactic Bivalent and Quadrivalent Human Papillomavirus (HPV) Vaccines: A Review
Immunogenicity of Antigen Adjuvanted with AS04 and Its Deposition in the Upper Respiratory Tract after Intranasal Administration
Novel Aspects and Strategies in Vaccination
Cytochrome B - Analysis of Hydrophobicity, Surface Accessibility,Antigenicity and Prediction of MHC I and MHC II Binders fromDracunculiasis
Novel Aspects and Strategies in Vaccination